hexamethylene bisacetamide and mitomycin

hexamethylene bisacetamide has been researched along with mitomycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kondo, K; Kume, T; Oishi, M; Shiraishi, T; Tsuneizumi, K; Watanabe, T1
Bortolasi, L; Dal Dosso, I; Facci, E; Mansueto, GC; Marchiori, L; Nicoli, N; Nifosi, F; Perus, G1

Trials

1 trial(s) available for hexamethylene bisacetamide and mitomycin

ArticleYear
[The treatment of hepatocellular carcinoma by chemoembolization].
    Chirurgia italiana, 1994, Volume: 46, Issue:1

    Topics: Acetamides; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Hepatocellular; Chemoembolization, Therapeutic; Female; Humans; Iodized Oil; Liver Neoplasms; Male; Middle Aged; Mitomycin; Neoplasm Recurrence, Local; Prognosis; Survival Analysis

1994

Other Studies

1 other study(ies) available for hexamethylene bisacetamide and mitomycin

ArticleYear
Synergistic induction of erythroid differentiation of mouse erythroleukemia (MEL) cells by inhibitors of topoisomerases and protein tyrosine kinases.
    Experimental cell research, 1992, Volume: 199, Issue:2

    Topics: Acetamides; Amsacrine; Animals; Blotting, Western; Camptothecin; Cell Differentiation; Cinnamates; Dimethyl Sulfoxide; Hemoglobins; Leukemia, Erythroblastic, Acute; Mice; Mitomycin; Protein-Tyrosine Kinases; Sulfides; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors; Tumor Cells, Cultured; Vanadates

1992